BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20372806)

  • 21. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
    Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC
    J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells.
    Daniels TR; Neacato II; Rodríguez JA; Pandha HS; Morgan R; Penichet ML
    Leukemia; 2010 Sep; 24(9):1555-65. PubMed ID: 20574452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
    Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X
    Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells.
    Bhardwaj A; Sethi G; Vadhan-Raj S; Bueso-Ramos C; Takada Y; Gaur U; Nair AS; Shishodia S; Aggarwal BB
    Blood; 2007 Mar; 109(6):2293-302. PubMed ID: 17164350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.
    Cortes-Sempere M; Chattopadhyay S; Rovira A; Rodriguez-Fanjul V; Belda-Iniesta C; Tapia M; Cejas P; Machado-Pinilla R; Manguan-García C; Sánchez-Pérez I; Nistal M; Moratilla C; de Castro-Carpeño J; Gonzalez-Barón M; Albanell J; Perona R
    Cancer Lett; 2009 Dec; 286(2):206-16. PubMed ID: 19553005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization.
    Baritaki S; Yeung K; Palladino M; Berenson J; Bonavida B
    Cancer Res; 2009 Nov; 69(21):8376-85. PubMed ID: 19843864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1.
    Leoh LS; Daniels-Wells TR; Martínez-Maza O; Penichet ML
    Mol Immunol; 2015 Oct; 67(2 Pt B):407-15. PubMed ID: 26232328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination Therapy of an Antibody Specific for Transferrin Receptor 1 (ch128.1/IgG1) With Bortezomib or Lenalidomide Results in Increased Survival in an In Vivo Model of Human Multiple Myeloma: A Brief Communication.
    Candelaria PV; Nava M; Martínez-Maza O; Daniels-Wells TR; Penichet ML
    J Immunother; 2022 Jun; 45(5):227-230. PubMed ID: 35467582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.
    Mitsiades CS; Mitsiades N; Poulaki V; Schlossman R; Akiyama M; Chauhan D; Hideshima T; Treon SP; Munshi NC; Richardson PG; Anderson KC
    Oncogene; 2002 Aug; 21(37):5673-83. PubMed ID: 12173037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Antibodies Targeting TfR1 in Xenograft Mouse Models of AIDS-Related Non-Hodgkin Lymphoma.
    Daniels-Wells TR; Candelaria PV; Kranz E; Wen J; Wang L; Kamata M; Almagro JC; Martínez-Maza O; Penichet ML
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.
    Rahman KM; Ali S; Aboukameel A; Sarkar SH; Wang Z; Philip PA; Sakr WA; Raz A
    Mol Cancer Ther; 2007 Oct; 6(10):2757-65. PubMed ID: 17913854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of AKT/NF‑κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatin.
    Dukaew N; Chairatvit K; Pitchakarn P; Imsumran A; Karinchai J; Tuntiwechapikul W; Wongnoppavich A
    Oncol Rep; 2020 Oct; 44(4):1441-1454. PubMed ID: 32945500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cells.
    Tsubaki M; Takeda T; Ogawa N; Sakamoto K; Shimaoka H; Fujita A; Itoh T; Imano M; Ishizaka T; Satou T; Nishida S
    Leuk Res; 2015 Apr; 39(4):445-52. PubMed ID: 25726084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway.
    Al-Bahlani S; Burney IA; Al-Dhahli B; Al-Kharusi S; Al-Kharousi F; Al-Kalbani A; Ahmed I
    BMC Pharmacol Toxicol; 2020 Sep; 21(1):64. PubMed ID: 32867831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon β improves the efficacy of low dose cisplatin by inhibiting NF-κB/p-Akt signaling on HeLa cells.
    Ethiraj P; Veerappan K; Samuel S; Sivapatham S
    Biomed Pharmacother; 2016 Aug; 82():124-32. PubMed ID: 27470347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis.
    Glazyrin AL; Chinni S; Alhasan S; Adsay VN; Vaitkevicius VK; Sarkar FH
    Int J Oncol; 2002 Jan; 20(1):201-5. PubMed ID: 11743665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
    FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galiximab signals B-NHL cells and inhibits the activities of NF-κB-induced YY1- and snail-resistant factors: mechanism of sensitization to apoptosis by chemoimmunotherapeutic drugs.
    Martinez-Paniagua MA; Vega MI; Huerta-Yepez S; Baritaki S; Vega GG; Hariharan K; Bonavida B
    Mol Cancer Ther; 2012 Mar; 11(3):572-81. PubMed ID: 22267549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway.
    Pandey MK; Sung B; Ahn KS; Kunnumakkara AB; Chaturvedi MM; Aggarwal BB
    Blood; 2007 Nov; 110(10):3517-25. PubMed ID: 17673602
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Zhang W; Hou J; Yan X; Leng J; Li R; Zhang J; Xing J; Chen C; Wang Z; Li W
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.